276 related articles for article (PubMed ID: 32797103)
21. Asymmetric Modification of Hepatitis B Virus (HBV) Genomes by an Endogenous Cytidine Deaminase inside HBV Cores Informs a Model of Reverse Transcription.
Nair S; Zlotnick A
J Virol; 2018 May; 92(10):. PubMed ID: 29491156
[TBL] [Abstract][Full Text] [Related]
22. APOBEC3 has not left an evolutionary footprint on the HIV-1 genome.
Ebrahimi D; Anwar F; Davenport MP
J Virol; 2011 Sep; 85(17):9139-46. PubMed ID: 21697498
[TBL] [Abstract][Full Text] [Related]
23. A Naturally Occurring Domestic Cat APOBEC3 Variant Confers Resistance to Feline Immunodeficiency Virus Infection.
Yoshikawa R; Izumi T; Yamada E; Nakano Y; Misawa N; Ren F; Carpenter MA; Ikeda T; Münk C; Harris RS; Miyazawa T; Koyanagi Y; Sato K
J Virol; 2016 Jan; 90(1):474-85. PubMed ID: 26491161
[TBL] [Abstract][Full Text] [Related]
24. [Molecular evolution of physiologically functioning anti-retroviral APOBEC3 deaminases].
Miyazawa M
Uirusu; 2012 Jun; 62(1):27-38. PubMed ID: 23189822
[TBL] [Abstract][Full Text] [Related]
25. Replacement of feline foamy virus bet by feline immunodeficiency virus vif yields replicative virus with novel vaccine candidate potential.
Ledesma-Feliciano C; Hagen S; Troyer R; Zheng X; Musselman E; Slavkovic Lukic D; Franke AM; Maeda D; Zielonka J; Münk C; Wei G; VandeWoude S; Löchelt M
Retrovirology; 2018 May; 15(1):38. PubMed ID: 29769087
[TBL] [Abstract][Full Text] [Related]
26. Mechanism of Enhanced HIV Restriction by Virion Coencapsidated Cytidine Deaminases APOBEC3F and APOBEC3G.
Ara A; Love RP; Follack TB; Ahmed KA; Adolph MB; Chelico L
J Virol; 2017 Feb; 91(3):. PubMed ID: 27881650
[TBL] [Abstract][Full Text] [Related]
27. In Vivo Examination of Mouse APOBEC3- and Human APOBEC3A- and APOBEC3G-Mediated Restriction of Parvovirus and Herpesvirus Infection in Mouse Models.
Nakaya Y; Stavrou S; Blouch K; Tattersall P; Ross SR
J Virol; 2016 Sep; 90(17):8005-12. PubMed ID: 27356895
[TBL] [Abstract][Full Text] [Related]
28. APOBEC3A damages the cellular genome during DNA replication.
Green AM; Landry S; Budagyan K; Avgousti DC; Shalhout S; Bhagwat AS; Weitzman MD
Cell Cycle; 2016; 15(7):998-1008. PubMed ID: 26918916
[TBL] [Abstract][Full Text] [Related]
29. Evidence for restriction of ancient primate gammaretroviruses by APOBEC3 but not TRIM5alpha proteins.
Perez-Caballero D; Soll SJ; Bieniasz PD
PLoS Pathog; 2008 Oct; 4(10):e1000181. PubMed ID: 18927623
[TBL] [Abstract][Full Text] [Related]
30. Footprint of APOBEC3 on the genome of human retroelements.
Anwar F; Davenport MP; Ebrahimi D
J Virol; 2013 Jul; 87(14):8195-204. PubMed ID: 23698293
[TBL] [Abstract][Full Text] [Related]
31. APOBEC3 genes: retroviral restriction factors to cancer drivers.
Henderson S; Fenton T
Trends Mol Med; 2015 May; 21(5):274-84. PubMed ID: 25820175
[TBL] [Abstract][Full Text] [Related]
32. Extensive editing of both hepatitis B virus DNA strands by APOBEC3 cytidine deaminases in vitro and in vivo.
Suspène R; Guétard D; Henry M; Sommer P; Wain-Hobson S; Vartanian JP
Proc Natl Acad Sci U S A; 2005 Jun; 102(23):8321-6. PubMed ID: 15919829
[TBL] [Abstract][Full Text] [Related]
33. The Battle between Retroviruses and APOBEC3 Genes: Its Past and Present.
Uriu K; Kosugi Y; Ito J; Sato K
Viruses; 2021 Jan; 13(1):. PubMed ID: 33477360
[TBL] [Abstract][Full Text] [Related]
34. APOBEC3 Host Restriction Factors of HIV-1 Can Change the Template Switching Frequency of Reverse Transcriptase.
Adolph MB; Ara A; Chelico L
J Mol Biol; 2019 Mar; 431(7):1339-1352. PubMed ID: 30797859
[TBL] [Abstract][Full Text] [Related]
35. Extensive editing of a small fraction of human T-cell leukemia virus type 1 genomes by four APOBEC3 cytidine deaminases.
Mahieux R; Suspène R; Delebecque F; Henry M; Schwartz O; Wain-Hobson S; Vartanian JP
J Gen Virol; 2005 Sep; 86(Pt 9):2489-2494. PubMed ID: 16099907
[TBL] [Abstract][Full Text] [Related]
36. APOBEC3 proteins and genomic stability: the high cost of a good defense.
Narvaiza I; Landry S; Weitzman MD
Cell Cycle; 2012 Jan; 11(1):33-8. PubMed ID: 22157092
[TBL] [Abstract][Full Text] [Related]
37. Vif determines the requirement for CBF-β in APOBEC3 degradation.
Yoshikawa R; Takeuchi JS; Yamada E; Nakano Y; Ren F; Tanaka H; Münk C; Harris RS; Miyazawa T; Koyanagi Y; Sato K
J Gen Virol; 2015 Apr; 96(Pt 4):887-892. PubMed ID: 25516542
[TBL] [Abstract][Full Text] [Related]
38. A metagenomic viral discovery approach identifies potential zoonotic and novel mammalian viruses in Neoromicia bats within South Africa.
Geldenhuys M; Mortlock M; Weyer J; Bezuidt O; Seamark ECJ; Kearney T; Gleasner C; Erkkila TH; Cui H; Markotter W
PLoS One; 2018; 13(3):e0194527. PubMed ID: 29579103
[TBL] [Abstract][Full Text] [Related]
39. [Cellular restriction factors that inhibit human immunodeficiency virus replication: new strategies in antiretroviral therapy].
Moreno-Valencia Y; Alvarez-García LX; Vázquez-Pérez JA
Rev Invest Clin; 2014; 66(4):359-68. PubMed ID: 25695302
[TBL] [Abstract][Full Text] [Related]
40. Role of the host restriction factor APOBEC3 on papillomavirus evolution.
Warren CJ; Van Doorslaer K; Pandey A; Espinosa JM; Pyeon D
Virus Evol; 2015 Jan; 1(1):. PubMed ID: 27570633
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
